KRT82

Across TCGA pan-cancer cohorts, KRT82 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated KRT82 data layer compared with 5 for mutation status.

The strongest signal is observed in kidney chromophobe (KICH), where higher KRT82 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRT82 expression acts as an unfavorable survival marker, although some lineages such as SARC and UCS show a favorable association.

KICH, COAD, and SKCM are the cancer types where KRT82 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.369	0.922	<.001	108	view →
COAD	OS	Tertile	IV	0.228	0.699	.002	48	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	45	view →
UCEC	DFS	Tertile	All	0.749	0.858	.003	30	view →
SCLC	DFS	Tertile	All	0.136	0.655	.006	24	view →
ACC	OS	Tertile	III,IV	0.251	0.613	.024	21	view →
MESO	OS	Tertile	All	0.375	0.592	.012	15	view →
SARC	DFS	Tertile	All	0.545	0.296	.005	13	view →
THCA	DFS	Tertile	IV	0.270	0.832	.014	12	view →
UCS	DFS	Median	III,IV	0.512	0.196	.015	10	view →
KIRC	DFS	Quartile	All	0.726	0.833	.010	10	view →
HNSC	OS	Quartile	All	0.737	0.511	.016	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

KRT82–KICH (DFS)

Open the KICH breakdown →